Caxton Associates LP Corcept Therapeutics Inc Transaction History
Caxton Associates LP
- $3.12 Billion
- Q4 2024
A detailed history of Caxton Associates LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Caxton Associates LP holds 10,632 shares of CORT stock, worth $803,141. This represents 0.02% of its overall portfolio holdings.
Number of Shares
10,632Holding current value
$803,141% of portfolio
0.02%Shares
7 transactions
Others Institutions Holding CORT
# of Institutions
478Shares Held
80.5MCall Options Held
596KPut Options Held
710K-
Black Rock Inc. New York, NY16.5MShares$1.25 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.54MShares$720 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.7MShares$582 Million20.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.09MShares$460 Million0.72% of portfolio
-
Parallel Advisors, LLC3.87MShares$292 Million6.09% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.09B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...